bayer-1
1 November 2013Patents

A giant’s perspective: interview with Bayer Group

In March 2012, global pharmaceutical company Bayer was dealt a blow which would mark a significant turning point for the entire industry.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
4 March 2013   India’s patent authorities have dealt a blow to German pharma company Bayer by refusing to overturn an order forcing the company to license one of its patented drugs.
Patents
1 January 2012   The Nexavar decision will be welcomed by patients in terms of affordability, but is a compulsory licence the best way to address the issue? Nita Sheikh asks the question.